Intragastric Balloon in Obese Adolescents With Comorbidities

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 26, 2017

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions

Obesity

Interventions

DEVICE

ORBERA™ Intragastric Balloon

The balloon will be inserted into the stomach and inflated, and will remain in place for 6 months, after which the device will be removed.

Trial Locations (1)

Mayo Clinic, Rochester

All Listed Sponsors

lead

Imad Absah

OTHER

NCT03233048 - Intragastric Balloon in Obese Adolescents With Comorbidities | Biotech Hunter | Biotech Hunter